Loading...

JBCHEPHARM J B Chemicals & Pharmaceuticals Ltd Changes in management or control Announcement

J B

JBCH

J B Chemicals & Pharmaceuticals Ltd

(JBCHEPHARM)

2025 Announcement

Regulatory Disclosure

Analyst call transcript

Conference call recording

Newspaper Advertisement

Scheme of Amalgamation

Final dividend recommendation

Q4/FY26 results

Audited annual results

Analyst / Investor Call

Board meeting intimation

Regulatory compliance certi...

CEO resignation

Tribunal Order Notice

Trading window closure

Corrigendum Order

Scheme of Amalgamation

Appointment of Directors an...

Tax penalty under GST

Senior Management Resignation

Postal Ballot Advertisement

Senior Management Resignation

CFO Appointment

Change of registered office

Board meeting intimation

Equity Offering

CFO resignation

Equity Investment

Encumbrance release

SAST disclosure

Off-market sale

Q3 FY26 Earnings Conference...

Reclassification Update

Change of control

Appointment of Directors

Equity Offering

Conference call recording

Newspaper advertisement

Investor Presentation

Q3 FY26 results

Quarterly results

Equity Investment in subsid...

Regulatory Compliance

Analyst Investor Call

Tax Assessment Order

Trading window closure

Tax ITC mismatch

ESG Score Release

Tax assessment order

Earnings Guidance / Confere...

Analyst call recording

Newspaper Advertisement

Investor Presentation

Q2 FY26 results

Unaudited Financials

Open Offer Announcement

Office Relocation

Investor Call Update

Investor Call Update

Board Meeting Notice

Compliance Certificate

Tax Orders Received

Open Offer Update

Director Change

Office Relocation

Appointment of Auditors

Statutory Auditor Re-appoin...

CEO Re-appointment

Director Re-appointment

Director Appointment

New Director Appointed

Investor Call Summary

Investor Call Audio

Financial Results Publication

Investor Presentation

Financial Results Q1

Investor Call Schedule

Annual Report Access

SEBI Compliance Certificate

AGM Notice Publication

Open Offer Notice

Director Appointment

Open Offer Announcement

Open Offer Update

Investor Presentation

Open Offer Announcement

Open Offer Announcement

Share Purchase Agreement

Office Relocation

Acquisition Announcement

Re-appointment of CEO

Share Transfer Notice

AGM Announcement

Analyst Meet Scheduled

Investor Call Transcript

Investor Call Audio

Financial Results

Secretarial Compliance

Secretarial Auditor Appoint...

Director Re-appointment

Director Appointment

Statutory Auditor Re-appoin...

Investor Presentation

Financial Results

Investor Meet Schedule

Compliance Certificate

Renewable Energy Acquisition

Cautionary Letter Noted

Cautionary Letter Received

USFDA Inspection

FDA Inspection Result

ESG Score Release

Tax Demand Received

Investor Meeting Schedule

Tax Demand Order

Analyst Call Transcript

Investor Call Audio

Financial Results Publication

Regulatory Fine Update

Investor Presentation

Financial Results Q3

Regulatory Order Received

Investor Call Announcement

Equity Shares Allotment

Investor Presentation

CGST Demand Order

Compliance Certificate

Equity Share Allotment

Investor Call Transcript

Investor Call Recording

Financial Results Published

Investor Presentation

Board Acknowledgment

Financial Results Q2

Investor Call Scheduled

Sustainability Report

Sustainability Report Launch

Regulatory Compliance

Capacity Addition

Analyst Meeting Scheduled

Investor Meetings

Tax Demand Notification

Tax Dispute Notice

Tax Demand Notice

Share Allotment Notice

Regulatory Fine

Tax Demand Notice

Investor Call Summary

Newspaper Publication

Investor Conferences

Equity Shares Allotment

Stock Option Grant

Financial Results

Newspaper Publication

Tax Demand Notice

Transfer of Equity Shares t...

Appointment Of Chairman

Director Appointment

Appointment of Director

Certificate Submission

Analyst Meeting Intimation

Newspaper Advertisement

Equity Shares Allotment und...

Director Appointment

Investor Call Results

Financial Results Publication

Investor Presentation

Financial Performance

Compliance Submission

Favorable Order Disclosure

Tax Demand Disclosure

Disclosure of GST Demand

Tax Demand Disclosure

Tax Demand Notice

Certificate Issuance

Compliance Certificate

Director Appointment

Certificate Submission

Tax Demand Appeal

Newspaper Publication

Investor Meeting Scheduled

Equity Allotment

Stock Options Grant

Stock Options Granted

Conference Call - Q3 FY24 E...

Audio Recording

Publication of Financial Re...

Financial Results

Financial Results Presentation

Appointment of Chief Financ...

Stock Options Allotment

Analysts/Investors Meet Sch...

Conference Call Scheduled

Regulatory Action

Presentation at Conference

Certificate Submission

Conference Call

Audio Recording

Regulatory Action

Resignation CFO

Allotment of ESOP

Conference Call

Investor Conferences

Financial Results Published

Regulatory Action

Equity Allotment

Stock Options Granted

Financial Results

Amendment to Employee Stock...

Appointment of Non-Executiv...

Conference Call Scheduled

Inspection by GST Department

Compliances-Certificate und...

Equity Allotment

ESG Report Published

Resignation of CFO

New Product Launches

Conference Call

Conference Call

Financial Statements

Financial Statements

Financial Statements

Equity Offerings

Analyst Meetings, Investor ...

Equity Offerings

Conference Call

Financial Statements, Earni...

Financial Statements

Divestment of Assets

No Observations

Equity Offerings

Earnings Call Transcript

Analyst/Institutional Inves...

Analyst/Investor Meeting

Financial Statements

Related Party Transactions ...

Presentation Release

Stock Splits, Dividend Policy

Stock Allotment

Management Changes

Conference Call

External Links:

Data:

Mr. Nikhil Chopra has been re-appointed as CEO and Whole-time Director of JB Chemicals & Pharmaceuticals Ltd for a 5-year term starting October 5, 2025.

AI Assistant

J B Chemicals & Pharmaceuticals Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.